A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

NCT04951076 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Traumatic Stress Disorder

Interventions

DRUG: BNC210
DRUG: Placebo

Sponsor

Bionomics Limited